{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12614102",
  "DateCompleted": {
    "Year": "2003",
    "Month": "03",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "06",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1539-3704",
      "JournalIssue": {
        "Volume": "138",
        "Issue": "5",
        "PubDate": {
          "Year": "2003",
          "Month": "Mar",
          "Day": "04"
        }
      },
      "Title": "Annals of internal medicine",
      "ISOAbbreviation": "Ann Intern Med"
    },
    "ArticleTitle": "Ciprofloxacin versus tobramycin for neutropenic fevers.",
    "Pagination": {
      "StartPage": "435",
      "EndPage": "436",
      "MedlinePgn": "435-6; author reply 436"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Linkin",
        "ForeName": "Darren R",
        "Initials": "DR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fishman",
        "ForeName": "Neil",
        "Initials": "N"
      }
    ],
    "PublicationTypeList": [
      "Comment",
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Ann Intern Med",
    "NlmUniqueID": "0372351",
    "ISSNLinking": "0003-4819"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Penicillins"
    },
    {
      "RegistryNumber": "5E8K9I0O4U",
      "NameOfSubstance": "Ciprofloxacin"
    },
    {
      "RegistryNumber": "VZ8RRZ51VK",
      "NameOfSubstance": "Tobramycin"
    },
    {
      "RegistryNumber": "X00B0D5O0E",
      "NameOfSubstance": "Piperacillin"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Ann Intern Med. 2002 Jul 16;137(2):77-87",
      "PMID": "12118962"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ciprofloxacin"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Drug Therapy, Combination"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Opportunistic Infections"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Penicillins"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Piperacillin"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Tobramycin"
    }
  ]
}